Ditchcarbon
  • Contact
  1. Organizations
  2. Fresenius Kabi USA, LLC
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 20 days ago

Fresenius Kabi USA, LLC Sustainability Profile

Company website

Fresenius Kabi USA, LLC, a prominent subsidiary of Fresenius Kabi AG, is headquartered in the United States and operates extensively across North America. Founded in 1996, the company has established itself as a leader in the healthcare industry, specialising in lifesaving medicines and technologies. Fresenius Kabi focuses on critical care, infusion therapy, and biosimilars, offering a diverse range of products that are distinguished by their quality and reliability. With a commitment to enhancing patient care, Fresenius Kabi has achieved significant milestones, including the development of innovative drug delivery systems and a robust portfolio of intravenous solutions. The company is recognised for its strong market position, consistently ranking among the top providers in its field, and is dedicated to advancing healthcare through sustainable practices and cutting-edge research.

DitchCarbon Score

How does Fresenius Kabi USA, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

46

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Fresenius Kabi USA, LLC's score of 46 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

64%

Let us know if this data was useful to you

Fresenius Kabi USA, LLC's reported carbon emissions

Inherited from Fresenius SE & Co. KGaA

Fresenius Kabi USA, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Fresenius SE & Co. KGaA, which cascades emissions data and climate commitments from its parent organisation. As of now, there are no documented reduction targets or climate pledges specific to Fresenius Kabi USA, LLC. The absence of specific initiatives or targets indicates a potential area for development in their sustainability strategy. The emissions data and performance metrics are inherited from Fresenius SE & Co. KGaA, which operates under broader industry standards for climate action. This relationship suggests that any climate commitments or emissions reductions would align with the overarching goals set by the parent company. In summary, while Fresenius Kabi USA, LLC does not currently report specific emissions figures or reduction targets, it is part of a larger corporate structure that may influence its future climate commitments and sustainability initiatives.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
521,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
1,013,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
0,000,000,000
0,000,000,000

How Carbon Intensive is Fresenius Kabi USA, LLC's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Fresenius Kabi USA, LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Fresenius Kabi USA, LLC's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Fresenius Kabi USA, LLC is in US, which has a low grid carbon intensity relative to other regions.

Fresenius Kabi USA, LLC's Scope 3 Categories Breakdown

Fresenius Kabi USA, LLC's Scope 3 emissions, which increased by 1% last year and increased by approximately 1% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 44% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
44%
Investments
31%
Employee Commuting
7%
Upstream Transportation & Distribution
6%
Fuel and Energy Related Activities
4%
Capital Goods
3%
End-of-Life Treatment of Sold Products
3%
Waste Generated in Operations
1%
Business Travel
<1%
Use of Sold Products
<1%

Fresenius Kabi USA, LLC's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Fresenius Kabi USA, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Fresenius Kabi USA, LLC's Emissions with Industry Peers

Meitheal Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Auro Medics Pharma Llc

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Hospira

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Kowa Pharmaceuticals America, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Dr. Reddy's Laboratories Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Apotex Corp.

US
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.5
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy